Literature DB >> 19289296

Adalimumab-induced neutropenia in a patient with rheumatoid arthritis.

Sébastien Ottaviani, Isabelle Cerf-Payrastre, Farid Kemiche, Edouard Pertuiset.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289296     DOI: 10.1016/j.jbspin.2008.09.017

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  6 in total

1.  Re-challenge with etanercept in patients with etanercept-induced neutropenia.

Authors:  Muhammad Haroon; Mary Daly; Sinead Harney
Journal:  Clin Rheumatol       Date:  2011-08-05       Impact factor: 2.980

Review 2.  Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.

Authors:  O Shovman; Y Shoenfeld; P Langevitz
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

3.  Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.

Authors:  Karel Pavelka; Alan Kivitz; Eva Dokoupilova; Ricardo Blanco; Marco Maradiaga; Hasan Tahir; Luminita Pricop; Mats Andersson; Aimee Readie; Brian Porter
Journal:  Arthritis Res Ther       Date:  2017-12-22       Impact factor: 5.156

Review 4.  State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies.

Authors:  Emmanuel Andrès; Noel Lorenzo Villalba; Abrar-Ahmad Zulfiqar; Khalid Serraj; Rachel Mourot-Cottet; And Jacques-Eric Gottenberg
Journal:  J Clin Med       Date:  2019-09-01       Impact factor: 4.241

5.  Therapy-Recalcitrant Folliculitis Decalvans Controlled Successfully with Adalimumab.

Authors:  Meshal M Alhameedy; Adel M Alsantali
Journal:  Int J Trichology       Date:  2019 Nov-Dec

6.  Current Perspectives on the Role of TNF in Hematopoiesis Using Mice With Humanization of TNF/LT System.

Authors:  Violetta S Gogoleva; Kamar-Sulu N Atretkhany; Arina P Dygay; Taisiya R Yurakova; Marina S Drutskaya; Sergei A Nedospasov
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.